Sylvia Jean Young - 14 Aug 2026 Form 4 Insider Report for Pediatrix Medical Group, Inc. (MD)

Reporting relationship: Director
Issuer ticker: MD
Reported as of: 14 Aug 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 18 Aug 2026, 17:00:02 UTC
Prior SEC filing: 14 Aug 2026
Source filing: View source filing
Reporting owner signature: /s/ David Haddock, Attorney-in-Fact

Key filing fact

Sylvia Jean Young filed Form 4 for Pediatrix Medical Group, Inc. (MD) on 18 Aug 2026.

Key facts

This page summarizes Sylvia Jean Young's Form 4 filing for Pediatrix Medical Group, Inc. (MD).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 18 Aug 2026, 17:00.

Change

Previous filing in this sequence was filed on 14 Aug 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001966642 Primary reporting owner

Young Sylvia Jean

Relationship: Director
Address: 1301 CONCORD TERRACE, SUNRISE
Signature: /s/ David Haddock, Attorney-in-Fact
Signature date: 18 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MD transaction

Common Stock

Disposed to Issuer

Transaction value
Shares: -18,500
Change %: -38%
Price: $26.62^*
Shares after: 29,786
Date: 14 Aug 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The price in Colum 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $26.51 to $26.80 for a weighted average sales price of $26.62. The reporting person undertakes to provide the issuer, any security holder of the issuer of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.